Company CVAbout Glaxosmithkline Pharmaceuticals Ltd 
Glaxosmithkline Pharmaceuticals Ltd
Mid Cap
Pharmaceuticals & Biotechnology
GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is headquartered in Mumbai and it has six branch offices, a manufacturing facility at Nashik in Maharashtra, 22 contract manufacturing organisations (CMOs) with regional and sales hubs across India.
Company Coordinates
Company Details
GSK House, Dr Annie Besant Road Worli Mumbai Maharashtra : 400030
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 169.41 Cr
Number of Shares
16.94 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
11-Sep-2018
16.94
169.41
84703017
10
Bonus
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 39 Schemes (5.05%)
FIIs
Held by 267 FIIs (4.8%)
Promoter with highest holding
Glaxo Group Limited (35.99%)
Highest Public shareholder
Lici Asm Non Par (1.15%)
Individual Investors Holdings
10.34%
Board of Directors
Management
Designation
Remuneration
D Sundaram
Independent Director
29.0 lacs
A A Nadkarni
Company Sec. & Compli. Officer
0
P V Bhide
Independent Director
28.5 lacs
A N Roy
Independent Director
25.0 lacs
Subesh Williams
Director
0
Renu S Karnad
Chairperson
35.5 lacs
Sunita Maheshwari
Independent Director
24.0 lacs
Manu Anand
Independent Director
23.03 lacs
Bhushan Akshikar
Managing Director
2.61 cr
J. Chandy
Whole Time Director & CFO
5.41 cr
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Goods
3,089.48
98.75%
Other Operating Income - Service Income
25.62
0.82%
Other Operating Income - Manufacturing Charges Recovery
9.23
0.29%
Pharmaceutical Goods
Pharmaceutical Goods
Other Operating Income - Service Income
Other Operating Income - Service Income
Other Operating Income - Manufacturing Charges Recovery
Other Operating Income - Manufacturing Charges Recovery
Stock DNARevenue and Profits:
Net Sales:
980 Cr
(Quarterly Results - Sep 2025)
Net Profit:
257 Cr
Pharmaceuticals & Biotechnology
INR 43,377 Cr (Mid Cap)
44.00
34
0.00%
-1.19
55.83%
24.83
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
